BioCentury
ARTICLE | Clinical News

AdVac tuberculosis vaccine: Phase II started

April 26, 2010 7:00 AM UTC

Crucell and the Aeras Global TB Vaccine Foundation began a double-blind, placebo-controlled, South African Phase II trial to evaluate intramuscular AERAS-402/Crucell Ad35 TB vaccine in adults infecte...